https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2015-08-25 06:44:242015-08-25 14:33:11China's Hepalink USA to Buy American Firm Cytovance for $205.68M+
Hepalink USA, the wholly owned U.S. subsidiary of Shenzhen Hepalink Pharmaceutical, will acquire the biopharmaceutical contract development manufacturing organization Cytovance® Biologics for $205.68 million cash plus additional contingent payments, Cytovance said today.
The deal adds a CDMO to Hepalink’s U.S. portfolio, which includes Scientific Protein Laboratories (SPL), a global supplier of active pharmaceutical ingredients (APIs). Hepalink and SPL together are one of the largest suppliers of heparin sodium API worldwide.
Help employers find you! Check out all the jobs and post your resume.
Source : http://www.biospace.com/news_story.aspx?StoryID=388988&full=1